SUPN - Financial Reports List - Supernus Pharmaceuticals, Inc. - IntrinsicAlpha

Supernus Pharmaceuticals, Inc. SUPN

Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US

$ 30.84

-1.53 %

$ 1.72 B

Market Cap

22.95

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	5.99%	1204.51%	12.72%
Annual Report	FY	10-K	2024-12-31	8.94%	5512.84%	1649.93%
Quarterly Report	Q3	8-K	2024-09-30	14.17%	340.97%	401.90%
Quarterly Report	Q2	8-K	2024-06-30	24.17%	2496.63%	203.57%
Quarterly Report	Q1	8-K	2024-03-31	-6.58%	-99.27%	-47.86%
Quarterly Report	Q4	8-K	2023-12-31	-1.80%	-95.39%	-44.69%
Annual Report	FY	10-K	2023-12-31	-8.95%	-97.83%	-7.83%
Quarterly Report	Q3	8-K	2023-09-30	-13.24%	-913.44%	360.82%
Quarterly Report	Q2	8-K	2023-06-30	-20.28%	-10.57%	-155.01%
Quarterly Report	Q1	8-K	2023-03-31	0.82%	-33.84%	-48.79%

1